Lionheart Health Announces Positive Results in Bioelectric Non-Invasive Breast Augmentation Preclinical Pilot and Safety Studies
Bioelectric stimulation approach designed to promote controlled endogenous tissue regeneration showed encouraging safety and tissue-growth findings in early animal studies; subsequent limited human studies reported no adverse events HUNTINGTON BEACH, Calif. —...
The “Arterial Cement” Problem: A Multi-Modal Strategy for Healthier Blood Pressure and Vascular Aging
Why Lionheart Health’s PressureStim™, Electro-Acupuncture, BodStim™ Exercise and Klotho-Up USA Program Target More Than a Number on a Blood-Pressure Cuff High blood pressure is often discussed as if the number itself were the disease. But an increasingly important...
Lionheart Health Launches New Hepatocyte Growth Factor (HGF) Studies as Part of its Klotho-Up™ Longevity Protocol
IRVINE, California — July 28, 2026 — Lionheart Health, Inc. today announced the launch of new clinical and translational research evaluating hepatocyte growth factor (HGF) as part of the company’s expanding Klotho-Up™ Protocol, a comprehensive multimodality program...
Leonhardt Ventures LLC, Lionheart Health, and CancerCell Prepare Provisional Patent Application for Bioelectric Expression of Thymulin Across Multiple Therapeutic Applications
Huntington Beach, California – July 28, 2026 — Leonhardt Ventures LLC, in collaboration with Lionheart Health, Inc. and CancerCell, Inc., today announced the preparation of a new U.S. provisional patent application covering novel methods and systems for...
Lionheart Health Announces Positive Pilot Clinical Trial Results for PressureStim™ Investigational Wellness Technology
Independent randomized clinical study demonstrates significant blood pressure reductions with sensory electrical stimulation applied over the kidney region HUNTINGTON BEACH, Calif. — July 30, 2026 — Lionheart Health, Inc. today announced encouraging results from an...
Leonhardt Ventures Announces Provisional Patent Application for Combination Osteoarthritis Therapy Featuring Pentadeca Arginate (PDA+) Licensed to Lionheart Health’s OrthoStim™ Platform
New investigational study arm to evaluate multimodality regenerative approach for joint health, mobility, inflammation, and healthy aging Huntington Beach, California — July 30, 2026 — Leonhardt Ventures LLC today announced the filing of a new provisional patent...
Lionheart Health and Leonhardt Ventures File Provisional Patent Covering Bioelectric Polylaminin Expression and Multi-Modal Spinal Cord Regeneration
Proposed SpineStim™ research program will evaluate noninvasive targeted bioelectric stimulation and BodStim™ alone and in combination with an injectable regenerative composition containing Klotho-expressing stem cells, polylaminin and a nutrient-rich hydrogel...
The Next Decade of Healthy Longevity: Why Technology May Become the Primary Driver of Healthspan Extension
A Forward-Looking Perspective Over the past century, improvements in life expectancy have been driven primarily by sanitation, vaccines, nutrition, and reductions in infectious disease. In the coming decade, however, the factors determining whether an individual...
Lionheart Health and Leonhardt Ventures File Provisional Patent Covering Bioelectric Polylaminin Expression and Multi-Modal Spinal Cord Regeneration
Proposed SpineStim™ research program will evaluate noninvasive targeted bioelectric stimulation and BodStim™ alone and in combination with an injectable regenerative composition containing Klotho-expressing stem cells, polylaminin and a nutrient-rich hydrogel...
Leonhardt Vineyards Releases Barrel-Aged 2023 Cabernet Sauvignon
Bold new Sonoma County vintage celebrates more than a quarter-century of Lionheart winemaking tradition SONOMA COUNTY, Calif. — July 22, 2026 — Leonhardt Vineyards today announced the release of its barrel-aged 2023 Cabernet Sauvignon, a distinctive Sonoma County...